Oral Session 1-9A Malignant Lymphoma: Diagnosis/Comorbidity/Others

[OS1-9A-1] A feasibility study of the comprehensive genetic analyses for DLBCL in clinical setting

Akihiro Tomita¹, Takahiko Yasuda², Masashi Sanada², Hiroaki Miyoshi³, Koichi Ohshima³, Kennosuke Karube⁴, Momoko Nishikori⁵, Hiroki Kurahashi⁶, Chisako Iriyama¹, Akinao Okamoto¹, Junji Hiraga⁷, Shigeru Kusumoto⁸, Noriko Fukuhara⁹, Matsuo Yamamoto², Akiko Saito², Hirokazu Nagai², Masataka Okamoto¹, Hiroyoshi Hattori², Takashi Kanamori^2,8, Dai Nishijima², Yuichi Shiraishi¹⁰, Satoru Miyano¹¹, Seishi Ogawa¹², Keizo Horibe² (1.Dept. Hematol., Fujita Health Univ., Toyoake, Japan, 2.Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, 3.Dept. Pathol., Kurume Univ. Sch. Med., Kurume, 4.Dept. Pathol. Cell Biol., Grad. Med., University of the Ryukyus, 5.Dept. Hematol Oncol, Kyoto Univ. Grad. Med., Kyoto, 6.Div. Mol. Genet., Inst. Comprehensive Med. Sci., Fujita Health Univ, 7.Dept. Hematol, Toyota Kosei Hospital, Toyota, 8.Dept Hematol Oncol, Nagoya City Univ Grad Sch Med Sci., 9.Dept. Hematol. Rheumatol., Tohoku Univ. Hosp., Sendai, 10.Center for Cancer Genomics and Advanced Therapeutics, National Cancer Center, 11.Human Genome Center, Inst. Med. Sci., Univ. Tokyo, Tokyo, 12.Dept. Pathol. Tumor Biol., Kyoto Univ., Kyoto)